Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
0.751
+0.007 (0.90%)
Nov 6, 2024, 4:00 PM EST - Market closed

Equillium Revenue

Equillium had revenue of $13.85M in the quarter ending June 30, 2024, with 51.83% growth. This brings the company's revenue in the last twelve months to $42.62M, up 26.25% year-over-year. In the year 2023, Equillium had annual revenue of $36.08M with 128.97% growth.

Revenue (ttm)
$42.62M
Revenue Growth
+26.25%
P/S Ratio
0.61
Revenue / Employee
$968,705
Employees
44
Market Cap
26.62M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202336.08M20.33M128.97%
Dec 31, 202215.76M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Burning Rock Biotech 70.15M
DarioHealth 19.15M
NeuroOne Medical Technologies 3.92M
Longeveron 1.23M
IGC Pharma 1.06M
Revenue Rankings